Release Date: 28/10/11 13:24 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 367.74KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%